glp-1 patient medications and weight loss: Helping patients navigate beyond the trends GLP-1s and Weight Loss Surgery:

The clinical differences are real but modest

Ania Jastreboff, an obesity medicine physician scientist at Yale University School of Medicine/Yale School of Medicine, co-Director of the Yale Center for Weight Management and the lead author on the phase 2 study, said that the results were striking and concluded that Retatrutide holds promise for substantial weight reduction in adults with obesity over a 48-week period

A 2025 SHRM article estimates a months supply to cost between $1,000 and $1,500

Effects of dapagliflozin on development and progression of kidney disease in patients with type 2 diabetes: an analysis from the DECLARE-TIMI 58 randomised trial

Though they found more benefits associated with the GLP-1 drugs than risks, study author Dr

Frustrated with diets that don't deliver